Question: Can you recommend a platform that offers high-throughput screening solutions for life science research and pharmaceutical development?

For high-throughput screening solutions in life science research and pharmaceutical development, Molecular Devices is a top platform. It has a broad portfolio of bioanalytical measurement solutions, including AI-driven cell culture systems, high-content confocal imaging, colony picker platforms, and more. These tools enable researchers to move to more complex, physiologically relevant 3D cell models, which can accelerate the development of life-saving therapeutics. The company's products are designed to meet GxP compliance requirements, so they can be used in both research and regulatory environments.

Another top choice is BenchSci, which offers the ASCEND platform for accelerating drug discovery and complex research workflows. This AI system ingests a large dataset, including closed access papers and patents, to interpret experiments from text and figures. With features like generative AI for summarization and conversational AI to help with experiment decisions, ASCEND can reduce experimental failures and improve the quality of research. The platform is geared for pharmaceutical and biotech R&D organizations looking to improve the speed and efficiency of their discoveries.

For AI-based solutions, Genesis Therapeutics offers the GEMS platform, which uses deep learning and molecular simulations to predict properties and generate molecules for new treatments. The platform enables researchers and developers to rapidly design high-potency and selective small molecule drugs. Genesis Therapeutics has demonstrated success in predicting ADMET properties, making it a useful tool for accelerating the discovery of new medicines.

Last, Ginkgo Bioworks offers a cell programming platform that uses biology to develop biotechnology solutions for a variety of markets, including biopharma. The platform includes services like enzyme and protein engineering, strain optimization, and biosecurity, all made possible by proprietary automation and software. Ginkgo Bioworks enables R&D teams to overcome biological challenges and get new products to market faster, making it a practical choice for high-throughput screening and biological innovation.